ACTRN12617000407392进行中(未招募)不适用
A multi-center, prospective, exploratory study of the psychosocial impact of donating haematopoietic stem cells on adult related donors
niversity of Queensland0 个研究点目标入组 41 人开始时间: 2017年3月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years(—)
- 性别
- All
入选标准
- •Group 1: Adult related stem cell transplant donors of planned allogeneic transplant recipients.
- •Group 2: Adult related lymphocyte donors of planned lymphocyte infusion recipients.
- •Group 3: BMT Nurses within the RBWH and Westmead Hospital Haematology and Bone Marrow Transplant Units.
- •1) Ages eligible for study: 18 to 70 years
- •2) Able to provide informed consent
排除标准
- •People whose primary language is other than English
- •Women who are pregnant and the human fetus
- •Children and/or young people (ie. <18 years)
- •People with a cognitive impairment, an intellectual disability or a mental illness
研究者
相似试验
招募中
不适用
A prospective, multicenter, observational study of the effects of SGLT2 inhibitors/ SPPARMalpha combination therapy on liver function in patients with type 2 diabetes and dyslipidemiatype 2 diabetes and dyslipidemiaJPRN-UMIN000043716niversity of Miyazaki50
尚未招募
不适用
A multicenter, prospective observational study of new criteria for sepsis (Sepsis-3)Sepsis (sepsis-3 criteria)JPRN-UMIN000036349Japanese Association for Acute Medicine600
已完成
不适用
A multicenter, prospective observational study of treatment and prognosis in patients with primary small bowel cancerSmall bowel cancerJPRN-UMIN000030361ational Hospital Organization Okayama Medical Center54
已完成
不适用
A multicenter, prospective observational study of pegfilgrastim for the management of febrile neutropenia during ramucirumab plus docetaxel for patients with advanced non-small cell lung cancer (CJLSG 1602)non-small cell lung cancerJPRN-UMIN000026927Central Japan Lung Study Group (CJLSG)35
招募中
不适用
A multicentre, observational, prospective study of the current practice in major centres in Australia and New Zealand for achieving haemostasis in consecutive patients who present with significant haemorrhage, thromboembolism or urgent surgery whilst on new or established oral anticoagulantsSignificant haemorrhageThromboembolismUrgent surgeryBlood - Other blood disordersACTRN12613001304729ARES Collaborative2,000
